The human chromosome 22-located genes and malignancies of the central nervous system

Neuropathology and Applied Neurobiology

Volumn 22, Issue 5, 1996, Pages 412-417

  Dumanski, J P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 22; CONFERENCE PAPER; GENE LOCATION; HUMAN; MENINGIOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029962469     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1996.tb00912.x     Document Type: Conference Paper

References (57)

1. 1 Akagi K, Kurahashi H, Arita N et al. Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 1995 ; 60: 178–82.
2. 2 Arinami T, Kondo I, Hamaguchi H, Nakajima S. Multifocal meningiomas in a patient with a constitutional ring chromosome 2. Med Genet 1986 ; 23: 178–80.
3. 3 Bijlsma EK, Brouwer‐Mladin R, Bosch DA, Westerveld A, Hulsebos TJM. Molecular characterization of chromosome 22 in schwannomas. Genes Chrom Cancer 1992 ; 5: 201–5.
4. 4 Bourn D, Carter SA, Mason S, Evans DGR, Strachan T. Germline mutations in the neurofibromatosis type two tumour suppressor gene. Hum Mol Genet 1994 ; 3: 813–6.
5. 5 Buijs A, Sherr S, Van Baal S et al. Translocation (12; 22) (p. 13; q11) in myeloproliferative disorders results in fusion of the ETS‐like TEL gene on 12p13 to the MM1 gene on 22q11. Oncogene 1995 ; 10: 1511–9.
6. 6 Collins JE, Cole CG, Smink LJ, Garrett CL, Leversha MA, Soderlund CA. A high density yeast artificial chromosome contig map of human chromosome 22. Nature 1995 ; 377: 367–79.
7. 7 Devilee P et al. Allelotype of human breast carcinoma; a second major site for loss of heterozygozity is on chromosome 6q. Oncogene 1991 ; 6: 1705–11.
8. 8 Dumanski JP, Carlbom E, Collins VP, Nordenskjöld M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci USA 1987 ; 84: 9275–9.
9. 9 Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma. In: Neurofibromatosis (Von Recklinghausen Disease); Genetics, Cell Biology and Biochemistry, Riccardi VM, Mulvihill JJ, Eds. New York: Raven Press, 1981: 57–65. Advances in Neurology; Vol. 29.
10. 10 Eldridge R, Parry DM, Kaiser‐Kupfer MI. Neurofibromatosis 2: clinical heterogeneity and natural history in 39 individuals in nine families and 16 sporadic cases. Am J Hum Gen 1991 ; 49: 32.
11. 11 Evans DGR, Huson SM, Donnai D et al. A genetic study of type two neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J. Med Genet 1992 ; 29: 841–6.
12. 12 Evans DGR, Huson SM, Donnai D et al. A genetic study of type two neurofibromatosis in the United Kingdom. II. Guidelines for genetic counseling. J. Med Genet 1992 ; 29: 847–52.
13. 13 Evans DGR, Huson M, Donnai D et al. A clinical study of type two neurofibromatosis. Q J Med 1992 ; 84: 603–18.
14. 14 James CD, He J, Carlbom E et al. Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chrom Cancer 1990 ; 2: 94–102.
15. 15 Kanter WR, Eldridge R, Fabricant R, Allen JC, Koerber T. Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 1980 ; 30: 851–9.
16. 16 Kaplan J‐C, Emanuel BS. Report of the committee on the genetic constitution of chromosome 22. Cytogenet Cell Genet 1989 ; 51: 372–83.
17. 17 Karayiorgou M, Morris MA, Morrow B et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 1995 ; 92: 7612–16.
18. 18 Kepes JJ. Meningiomas: Biology, Pathology and Differential Diagnosis. New York: Masson Publishing, Inc. USA, 1982.
19. 19 Larsson C, Byström C, Skoog L, Rotstein S, Nordenskjöld M. Genomic alterations in human breast carcinomas. Genes Chrom Cancer 1990 ; 2: 191–7.
20. 20 Lekanne Deprez RH, Groen NA, Louz D et al. Constitutional DNA‐level aberrations in chromosome 22 in a patient with multiple meningiomas. Genes Chrom Cancer 1994 ; 9: 124–8.
21. 21 Lekanne Deprez RH, Bianchi AB, Groen NA et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994 ; 54: 1022–9.
22. 22 Lekanne Deprez RH, Riegman PHJ, Groen NA et al. Cloning and characterization of MN1, a gene from chromosome 22q11 which is disrupted by a balanced translocation in a meningioma. Oncogene 1995 ; 10: 1521–8.
23. 23 Lekanne Deprez RH, Riegman PH, Van Drunen E et al. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J. Neuropathol Exp Neurol 1995 ; 54: 224–35.
24. 24 Lindblom A, Ruttledge M, Collins VP, Nordenskjöld M, Dumanski JP. Chromosomal deletions in anaplastic meningiomas suggest mutiple regions outside chromosome 22 as important for the tumour development and progression. Int J Cancer 1994 ; 56: 354–7.
25. 25 Lindblom A, Sandelin K, Iselius L et al. Predisposition for breast cancer in carriers of constitutional translocation 11q; 22q. Am J Hum Genet 1994 ; 54: 871–6.
26. 26 MacCollin MM, Mohney T, Trofatter JA, Wertelecki W, Ramesh V, Gusella JF. DNA diagnosis of neurofibromatosis 2. JAMA 1993 ; 270: 2316–20.
27. 27 Meese E, Blin N, Zang KD. Loss of heterozygozity and the origin of meningioma. Hum Genet 1987 ; 77: 349–51.
28. 28 Merel P, Hoang‐Xuan K, Sanson M et al. Screening for germ line mutations in the NF2 gene. Genes Chrom Cancer 1995 ; 12: 117–27.
29. 29 Merel P, Hoang‐Xuan K, Sanson M et al. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chrom Cancer 1995 ; 13: 211–6.
30. 30 Nesslinger N, GorsKi JL, Kurczynski TW et al. Clinical, cytogenetic and molecular characterization of seven patients with deletions of chromosome 22q13.3. Am J Hum Genet 1994 ; 54: 464–72.
31. 31 Okamoto M, Sasaki M, Sugio K et al. Loss of constitutional heterozygozity in colon carcinoma from patients with familial polyposis coli. Nature 1988 ; 331: 273–7.
32. 32 Pedeutour F, Simon M‐P, Minoletti F et al. Ring chromosomes in dermatofibrosarcoma protuberans are low‐level amplifiers of chromosome 17 and 22 sequences. Cancer Res 1995 ; 55: 2400–3.
33. 33 Petrella R, Lewine S, Wilmot PL, Ashar KD, Casamassima AC, Shapiro LR. Multiple meningiomas in a patient with constitutional ring chromosome 22. Am J Med Genet 1993 ; 47: 184–6.
34. 34 Peyrard M, Fransson I, Xie Y‐G et al. Characterization of a new member of the human β‐adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum Mol Genet 1994 ; 3: 1393–9.
35. 35 Pulver AE, Karayiorgou M, Wolyniec PS. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12–q13.1. Am J Med Genet (Neuropsych Genet) 1994 ; 54: 36–43.
36. 36 Rey JA, Bello MJ, de Campos JM, Kusak E, Moreno S. Chromosomal involvement secondary to—22 in human meningiomas. Cancer Genet Cytogenet 1988 ; 33: 275–90.
37. 37 Rey JA, Bello MJ, Jimenez‐Lara AM et al. Loss of heterozygozity for distal markers on 22q in human gliomas. Int J Cancer 1992 ; 51: 703–6.
38. 38 Robinson MS. The role of clathrin, adaptors and dynamin in endocytosis. Current Opin Cell Biol 1994 ; 6: 538–44.
39. 39 Rouleau GA, Merel P, Lutchman M et al. Alteration of a new gene encoding a putative membrane organizing protein causes neurofibromatosis type 2. Nature 1993 ; 363: 515–21.
40. 40 Rouleau GA, Wertelecki W, Haines JL et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 1987 ; 329: 246–8.
41. 41 Russell DS, Rubinstein LJ. Pathology of the Tumours of the Nervous System. London: Edward Arnold, 1989.
42. 42 Ruttledge MH, Narod SA, Dumanski JD et al. Pre‐symptomatic diagnosis for neurofibromatosis two with chromosome 22 markers. Neurology 1993 ; 43: 1753–60.
43. 43 Ruttledge MH, Sarrazin J, Rangaratnam S et al. Evidence for the complete inactivation of the neurofibromatosis type two gene in the majority of sporadic meningiomas. Nature Genet 1994 ; 6: 180–4.
44. 44 Ruttledge MH, Xie Y‐G, Han F‐Y et al. Deletions on chromosome 22 in sporadic meningioma. Genes Chrom Cancer 1994 ; 10: 122–30.
45. 45 Scambler PJ. Report and abstracts of the Fourth International Workshop on Human Chromosome 22 Mapping 1994. Cytogenet Cell Genet 1994 ; 67: 277–94.
46. 46 Seizinger BR de Monte S, Atkins L, Gusella JF, Martuza RL. Molecular genetic approach to human meningioma: Loss of genes on chromosome 22. Proc Natl Acad Sci USA 1987 ; 84: 5419–23.
47. 47 Sanson M, Marineau C, Desmaze C et al. Germline deletion in a neurofibromatosis type two kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet 1993 ; 2: 1215–20.
48. 48 Sekido Y, Pass HI, Bader S et al. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 1995 ; 55: 1227–31.
49. 49 Simon M, von Detailing A, Larson JJ et al. Allelic losses on chromosomes; 14: 10, and 1 in atypical meningiomas: agenetic model of meningioma progression. Cancer Res: in press.
50. 50 Tanaka N, Nishisho I, Yamamoto M et al. Loss of heterozygozity on the long arm of chromosome 22 in pheo‐chromocytoma. Genes Chrom Cancer 1992 ; 5: 399–403.
51. 51 Trofatter JA, MacCollin MM, Rutter JL et al. A novel moesin‐, ezrin‐, radixin‐like gene is a candidate for the neurofibromatosis two tumor supressor. Cell 1993 ; 72: 791–800.
52. 52 Watson CJ, Gaunt L, Evans G, Patel K, Harris R, Strachan T. A disease associated germline deletion maps the type two neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukemia inhibitory factor locus. Hum Molec Genet 1993 ; 2: 701–4.
53. 53 Xie Y‐G, Han F‐Y, Peyrard M et al. Cloning of a novel, anonymous gene from a megabase‐range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12. Human Molec Genet 1993 ; 2: 1361–8.
54. 54 Yana I, Kurahashi H, Nakamori S et al. Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers. Int J Cancer 1995 ; 60: 174–7.
55. 55 Zankl H, Weiss AF, Zang KD. Cytological and cytogenetical studies on brain tumors VI. No evidence for a translocation in 22‐monosomic meningiomas. Humangenetik 1975 ; 30: 343–8.
56. 56 Zankl H, Zang KD. Cytological and cytogenetical studies on brain tumors. III. Phi‐like chromosomes in human meningiomas. Humangenetik 1971 ; 12: 42–9.
57. 57 Zankl H, Zang KD. Correlations between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1980 ; 1: 351–56.